[Update on ischemic heart disease]
José A Barrabés1, Juan Sanchís, Pedro L Sánchez
1Servicio de Cardiología, Hospital Universitario Vall d'Hebron, Barcelona, España. jabarrabes@vhebron.net
Revista Espanola De Cardiologia
|January 29, 2009
Insights
This review covers 2008 advancements in acute coronary syndrome (ACS) pathophysiology, prevention, prognosis, and treatment. It also summarizes the latest clinical practice guidelines for managing ACS.
Area of Science:
- Cardiology
- Internal Medicine
Context:
- Review of 2008 scientific literature and presentations.
- Focus on ST-segment elevation and non-ST-segment elevation acute coronary syndromes.
Purpose:
- Summarize key developments in acute coronary syndrome (ACS) research.
- Discuss the latest clinical practice guidelines for ACS management.
Summary:
- Covers pathophysiology, secondary prevention, prognosis, and treatment of ACS.
- Highlights significant findings reported in publications and presentations during 2008.
- Includes a discussion of current clinical practice guidelines.
Impact:
- Provides a concise overview of recent ACS advancements.
- Aids clinicians and researchers in staying updated on acute coronary syndrome.
- Facilitates understanding of evolving ACS treatment strategies and guidelines.
Abstract:
This article contains a review of the main developments reported during 2008 in either publications or presentations on the pathophysiology, secondary prevention, prognosis or treatment of ST-segment elevation, or non-ST-segment elevation acute coronary syndrome. The latest clinical practice guidelines are also summarized and discussed.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...